↓ Skip to main content

Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials

Overview of attention for article published in The Journal of Headache and Pain, June 2020
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
Published in
The Journal of Headache and Pain, June 2020
DOI 10.1186/s10194-020-01148-9
Pubmed ID
Authors

Virginia L. Stauffer, Ira Turner, Phebe Kemmer, William Kielbasa, Kathleen Day, Martha Port, Tonya Quinlan, Angelo Camporeale

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 14%
Researcher 7 11%
Student > Bachelor 7 11%
Student > Master 5 8%
Librarian 2 3%
Other 2 3%
Unknown 32 50%
Readers by discipline Count As %
Medicine and Dentistry 13 20%
Neuroscience 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Nursing and Health Professions 3 5%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 3 5%
Unknown 32 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2020.
All research outputs
#18,572,005
of 23,849,058 outputs
Outputs from The Journal of Headache and Pain
#1,172
of 1,417 outputs
Outputs of similar age
#288,524
of 402,279 outputs
Outputs of similar age from The Journal of Headache and Pain
#46
of 51 outputs
Altmetric has tracked 23,849,058 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,417 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.6. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,279 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.